Exagen Inc. Reports Preliminary Unaudited Revenue Results for the Quarter Ended December 31, 2020
Exagen Inc. reported preliminary unaudited revenue results for the quarter ended December 31, 2020. Testing revenue for the three months ended December 31, 2020 is expected to be between approximately $10.5 million and $10.8 million, an increase of 11% and 15% compared with $9.5 million in the third quarter of 2020, and an increase of 10% to 13% compared with $9.6 million in the fourth quarter of 2019.